/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

J

Joel Picus

Barnes-Jewish Hospital(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

370

Papers

26.2K

Citations

65

h-index

155

i10-index

Joel Picus is an academic researcher from Barnes-Jewish Hospital. The author has contributed to research in topics: Prostate Cancer Treatment and Research & Renal cell carcinoma treatment & Colorectal Cancer Treatments and Studies. The author has an h-index of 65, co-authored 315 publications.

ORCID: 0000-0002-4038-936X

Research Topics

Prostate Cancer Treatment and Research Renal cell carcinoma treatment Colorectal Cancer Treatments and Studies Bladder and Urothelial Cancer Treatments Cancer Immunotherapy and Biomarkers

Papers by this author

works

Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal Cancer

2008 · Journal of Clinical Oncology · 1,835 citations

https://doi.org/10.1200/jco.2007.15.8923

Steven J. Cohen Cornelis J.A. Punt Nicholas Iannotti Bruce Saidman

Phase III Trial of Bevacizumab Plus Interferon Alfa Versus Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: Final Results of CALGB 90206

2010 · Journal of Clinical Oncology · 788 citations

https://doi.org/10.1200/jco.2009.26.5561

Brian I. Rini Susan Halabi Jonathan E. Rosenberg Walter M. Stadler

A Phase 1 study of UCN-01 in combination with irinotecan in patients with resistant solid tumor malignancies

2010 · Cancer Chemotherapy and Pharmacology · 68 citations

https://doi.org/10.1007/s00280-010-1410-1

Paula M. Fracasso Kerry J. Williams Ronald C. Chen Joel Picus

Apatorsen plus docetaxel versus docetaxel alone in platinum-resistant metastatic urothelial carcinoma (Borealis-2)

2018 · British Journal of Cancer · 42 citations

https://doi.org/10.1038/s41416-018-0087-9

Jacob Rosenberg Noah M. Hahn Meredith M. Regan Lillian Werner

Phase I study of pegylated liposomal doxorubicin and the multidrug-resistance modulator, valspodar

2005 · British Journal of Cancer · 27 citations

https://doi.org/10.1038/sj.bjc.6602653

Paula M. Fracasso Kristie A. Blum Mitra Subrata k Benjamin Tan

A propensity analysis comparing definitive chemo-radiotherapy for muscle-invasive squamous cell carcinoma of the bladder vs. urothelial carcinoma of the bladder using the National Cancer Database

2018 · Clinical and Translational Radiation Oncology · 20 citations

https://doi.org/10.1016/j.ctro.2018.12.001

Benjamin W. Fischer‐Valuck Jeff M. Michalski J. Contreras Randall Brenneman

Research topics

topics

Prostate Cancer Treatment and Research

Renal cell carcinoma treatment

Colorectal Cancer Treatments and Studies

Bladder and Urothelial Cancer Treatments

Cancer Immunotherapy and Biomarkers

Chat about Author

Papers

Chat

Click to start Chat